Loading people...
Boris Nikolic is the Co-Founder and Managing Director of Biomatics Capital Partners, based in Seattle, Washington. Before launching the firm in 2016, he served as Chief Advisor for Science and Technology to Bill Gates and held an assistant professorship at Harvard Medical School. Through Biomatics Capital, he co-managed significant investment vehicles, including a $300 million second fund closed in 2018, to back early-stage life sciences companies. His portfolio includes participation in a $120 million round for Editas Medicine, a $61 million round for Twist Biosciences, and early backing for diagnostics developer Grail. Following a period of reduced activity after declining an unexpected executor appointment in Jeffrey Epstein's will in 2019, he returned to the market with a new biotechnology fund in 2024. Nikolic currently focuses on investments at the intersection of genomics, synthetic biology, and data-driven healthcare innovations.
Boris Nikolic is a distinguished Managing Director at Biomatics Capital Partners, a leading venture capital firm dedicated to fostering innovation in the life sciences and deep technology sectors. In his pivotal role, Mr. Nikolic is instrumental in shaping the firm's investment strategy, identifying high-potential startups, and guiding them through critical growth phases. His leadership is central to Biomatics Capital Partners' mission of investing in companies poised to revolutionize healthcare, biotechnology, and scientific research.
Mr. Nikolic's investment focus at Biomatics Capital Partners spans a broad spectrum of cutting-edge areas. He is particularly interested in biotechnology, pharmaceuticals, medical devices, diagnostics, and health technology. Furthermore, his expertise extends to deep technology applications within these fields, including artificial intelligence in drug discovery, advanced genomics, synthetic biology, and novel therapeutic platforms. He seeks out companies with robust scientific foundations, proprietary technologies, and strong management teams capable of executing ambitious visions.
Prior to his tenure at Biomatics Capital Partners, Boris Nikolic built a formidable career marked by significant contributions across scientific research, corporate development, and venture capital. His background likely includes a strong academic foundation in life sciences or a related technical discipline, potentially coupled with experience in leading R&D initiatives or strategic partnerships within established biotech or pharmaceutical companies. This diverse experience provides him with a unique perspective, enabling him to thoroughly evaluate complex scientific propositions and understand the market dynamics crucial for successful commercialization.
While specific public details of his notable investments are not always disclosed, Mr. Nikolic's work at Biomatics Capital Partners consistently involves identifying and backing companies that are developing transformative solutions. He is known for his rigorous due diligence process and his commitment to partnering with founders to accelerate their scientific breakthroughs into viable market products. His strategic insights and deep industry network are invaluable assets to the portfolio companies he supports, helping them navigate challenges and achieve their growth objectives in highly competitive landscapes. Through his efforts, Boris Nikolic continues to play a vital role in advancing innovation and driving significant impact within the global life sciences ecosystem.
Boris Nikolic is a Managing Director at Biomatics Capital Partners, a venture capital firm specializing in life sciences and deep technology investments.
Boris Nikolic invests in companies across biotechnology, pharmaceuticals, medical devices, diagnostics, health technology, and deep technology applications like AI in drug discovery and advanced genomics.
Boris Nikolic works as a Managing Director at Biomatics Capital Partners.
